z-logo
open-access-imgOpen Access
2SPD-010 Assessment of pertuzumab use for her2-positive breast cancer treatment
Author(s) -
JF Marín Pozo,
M Merino Almazán,
A Sánchez Ruíz,
A.M. López,
R Claramunt García,
CL Muñoz Cid
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.31
Subject(s) - pertuzumab , medicine , trastuzumab , breast cancer , metastatic breast cancer , chemotherapy , oncology , retrospective cohort study , medical record , cancer , lapatinib

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom